LILRB2 and neoplasm: In contrast, pretreatment of tumor cells with either anti-ILT4 or anti-PD-L1 antibodies yielded lower apoptosis of T cells compared with the control IgG group, and the combination treatment generated the least number of apoptotic T cells (Figure 5L-M).